Vir: BARDA to fund Antibody Platform Technologies for Global Infectious Disease

 New investment of approximately $50 million from Biomedical Advanced Research and Development Authority includes $40 million in Project NextGen funds –

– Contract expands existing support for the development of candidates for prevention and treatment of pathogens of pandemic potential –

https://www.globenewswire.com/news-release/2023/10/03/2753536/0/en/Vir-Biotechnology-Awarded-BARDA-Funding-to-Support-Development-of-Antibody-Platform-Technologies-for-Global-Infectious-Disease-Threats.html